Helen Frankenthaler Foundation

Wholesale API from China Manufacturer

China Acetyl Tetrapeptide-3 827306-88-7 Product Information

Acetyl Tetrapeptide-3 827306-88-7

Customer support: admin@frankenthalerfoundation.org

Contact Us: +(86)592-5853819

Product Details

Product Information
Product nameAcetyl tetrapeptide-3
CAS No.827306-88-7
SequenceN2-Acetyl-L-lysylglycyl-L-histidyl-L-lysinamide
Molecular FormulaC22H39N9O5
Molecular Weight509.6
Quality Standard98% up by HPLC
AppearanceWhite powder
COA of Acetyl tetrapeptide-3
ITEMSPECIFICATIONSRESULTS
Physical Control
AppearanceWhite PowderConforms
OdorCharacteristicConforms
TasteCharacteristicConforms
Purity98%Conforms
Loss on Drying≤5.0%Conforms
Ash≤5.0%Conforms
Particle size95% pass 80 meshConforms
AllergensNoneConforms
Chemical Control
Heavy metalsNMT 10ppmConforms
ArsenicNMT 2ppmConforms
LeadNMT 2ppmConforms
CadmiumNMT 2ppmConforms
MercuryNMT 2ppmConforms
GMO StatusGMO FreeConforms
Microbiological Control
Total Plate Count10,000cfu/g MaxConforms
Yeast & Mold1,000cfu/g MaxConforms
E.ColiNegativeNegative
SalmonellaNegativeNegative
Conclusion: Conforms with standards.
Usage

Acetyl tetrapeptide-3 is a beauty polypeptide containing four amino acids. This peptide can quickly repair hair follicle cells, stimulate the natural growth of eyebrows and hair, and can effectively reduce hair loss caused by aging, making eyebrows and hair thicker and more natural , Supple and firm.

Function of Acetyl tetrapeptide-3
  • hair growth stimulant,improves hair anchoring
  • Enhancing the appearance of eyelashes and/or eyebrows
Application of Acetyl tetrapeptide-3
  • Reduces hair loss;
  • Boosts hair regrowth;
  • Improves follicle health and anchoring of hair to the root;
  • Reduces inflammation of the scalp

Hot Tags : Acetyl tetrapeptide-3 Acetyl tetrapeptide Capixyl Ac-KGHK cosmetic peptide manufacturers polypeptide powder

Related Products

Syn-Coll/ Palmitoyl Tripeptide-5 623172-56-5 - 99% up by HPLC

Linaclotide 851199-59-2 - 98% up, Medical Grade

Alarelin Acetate 79561-22-1 - 98% up by HPLC

Matrixyl Palmitoyl Pentapeptide-4 214047-00-4 - 99% up by HPLC

Liraglutide 204656-20-2 - Product Information Product name Liraglutide Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu- Glu-Gly-Gln-Ala-Ala-Lys[N6-[N-(1-oxohexadecyl)-L-γ-glutamyl]- -Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH CAS No. 204656-20-2 Molecular Formula C172H265N43O51 Molecular Weight 3751.20 Storage 2~8℃ Appearance White to off-white crystalline powder COA of Liraglutide Test Specification Results Appearance: White to off-white crystalline powder or lumps White powder Identity: 3751.2±1.0 3751.1 Purity (By HPLC) : Not Less than 98.0%; 99.51% Residual solvents: ≤0.25%total; ≤0.1%individual; ≤0.01%CH2CN Complies Related Peptide Total Impurity ≤ 2.0% Largest Single Impurity ≤ 1.0% TI =0.41% LSI =0.25% Peptide Content: Not Less than 85.0% 87.7% Water (K.F.): Not more than 5% 4.2% Acetate acid: Not more than 10% 8.1% Bacterial Endotoxins Not more than 50IU/mg Complies Usage Function and Usage of Liraglutide 204656-20-2 1、 Type 2 diabetes Liraglutide improves control of blood glucose.It reduces meal-related hyperglycemia (for 24 hours after administration) by increasing insulin secretion (only) when required by increasing glucose levels, delaying gastric emptying, and suppressing prandial glucagon secretion. In common to various degrees with other GLP-1 receptor agonists, liraglutide has advantages over more traditional therapies for type 2 diabetes: · Liraglutide acts in a glucose-dependent manner, meaning it will stimulate insulin secretion only when blood glucose levels are higher than normal, preventing "overshoot". Consequently, it shows negligible risk of hypoglycemia. · Liraglutide has the potential for inhibiting apoptosis and stimulating regeneration of beta cells (seen in animal studies). · Liraglutide decreases appetite and inhibits body weight gain, as shown in a head-to-head study versus glimepiride. · Liraglutide lowers blood triglyceride levels. 2、Obesity Liraglutide has been approved as an injectable adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult pa